Vuxen Group (VUXEN) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
17 Mar, 2026Executive summary
Net sales increased by 8.5% to 67.3 MSEK in Q3 24/25 compared to 62.0 MSEK last year, with continued profitable growth and international expansion, notably in Germany and the EU.
EBITDA for Q3 was 3.6 MSEK (5.3% margin), down from 4.3 MSEK (7.0%) year-over-year, reflecting higher external costs and personnel expenses.
The company is rebranding from Purefun Group to Vuxen Group to clarify its identity and focus on sexual wellness brands.
Financial highlights
Gross margin for Q3 was 58.2%, down from 59.8% year-over-year; for the nine-month period, gross margin was 58.6% (up from 58.1%).
EBIT for Q3 was 1.8 MSEK (2.6% margin), down from 2.5 MSEK (4.0%) year-over-year.
Net income for Q3 was 1.6 MSEK, compared to 2.3 MSEK last year.
Cash flow from operations for May–Jan was 5.3 MSEK, down from 8.0 MSEK year-over-year.
Solid equity ratio at 72.3% as of the balance date, up from 68.4% last year.
Outlook and guidance
Management sees strong potential for continued profitable international growth, supported by a robust financial position and improved consumer climate in some markets.
The company is well positioned for further expansion, with a focus on customer offering, service, and competitive pricing.
Latest events from Vuxen Group
- Q3 delivered 19% sales growth and 80% higher EBITDA, with robust cash flow and margins.VUXEN
Q3 25/2626 Mar 2026 - Q2 delivered strong growth and profitability, with core segment focus boosting margins.VUXEN
Q2 25/2619 Dec 2025 - Sales up 6.1% and EBITDA margin at 8.8%, driven by focus on sexual health and efficiency.VUXEN
Q1 25/2625 Sep 2025 - Sales rose 5.1% year-over-year, but margins and net income declined amid market headwinds.VUXEN
Q4 24/2527 Jun 2025 - Q2 sales up 6.3% with robust margins; growth accelerates into Q3 on strong holiday demand.VUXEN
Q2 24/2513 Jun 2025 - Stable sales and profitability amid retail headwinds, with growth focus on core and new markets.VUXEN
Q1 24/2513 Jun 2025 - Record revenue and margin gains achieved through international expansion and own brands.VUXEN
Q4 23/2413 Jun 2025